Cefoxitin Injection, Powder, For Solution
Product Images NDC 25021-110
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefoxitin (NDC 25021-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Creatinine Conversion Formula (Cef0d 0011 02)
Package Label – Principal Display Panel – Vial Label (Cef0d 0011 03)
Package Label – Principal Display Panel – Vial Label (Cef0d 0011 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.